English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 158 | Tables: 159 | Pharma & Healthcare
In 2024, the global market size of Famciclovir API was estimated to be worth US$ 13.6 million and is forecast to reach approximately US$ 15.9 million by 2031 with a CAGR of 2.3% during the forecast period 2025-2031.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Famciclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir API.
The Famciclovir API market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Famciclovir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Segment by Type
Insourced
Outsourced
Others
Segment by Application
Tablet Product
Capsule Product
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Famciclovir API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Famciclovir API sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Famciclovir API Product Introduction
1.2 Market by Type
1.2.1 Global Famciclovir API Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Insourced
1.2.3 Outsourced
1.2.4 Others
1.3 Market by Application
1.3.1 Global Famciclovir API Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Tablet Product
1.3.3 Capsule Product
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Famciclovir API Market Size Estimates and Forecasts
2.1.1 Global Famciclovir API Revenue 2020-2031
2.1.2 Global Famciclovir API Sales 2020-2031
2.2 Famciclovir API Market Size by Region: 2024 Versus 2031
2.3 Famciclovir API Sales by Region (2020-2031)
2.3.1 Global Famciclovir API Sales by Region: 2020-2025
2.3.2 Global Famciclovir API Sales Forecast by Region (2026-2031)
2.3.3 Global Famciclovir API Sales Market Share by Region (2020-2031)
2.4 Famciclovir API Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Famciclovir API Revenue by Region: 2020-2025
2.4.2 Global Famciclovir API Revenue Forecast by Region (2026-2031)
2.4.3 Global Famciclovir API Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Famciclovir API Sales by Type (2020-2031)
3.1.1.1 Global Famciclovir API Sales Volume by Type (2020-2031)
3.1.1.2 Global Famciclovir API Sales Market Share by Type (2020-2031)
3.1.2 Global Famciclovir API Revenue by Type (2020-2031)
3.1.2.1 Global Famciclovir API Revenue by Type (2020-2031)
3.1.2.2 Global Famciclovir API Revenue Market Share by Type (2020-2031)
3.1.3 Famciclovir API Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Famciclovir API Sales by Application (2020-2031)
3.2.1.1 Global Famciclovir API Sales Volume by Application (2020-2031)
3.2.1.2 Global Famciclovir API Sales Market Share by Application (2020-2031)
3.2.2 Global Famciclovir API Revenue by Application (2020-2031)
3.2.2.1 Global Famciclovir API Revenue by Application (2020-2031)
3.2.2.2 Global Famciclovir API Revenue Market Share by Application (2020-2031)
3.2.3 Famciclovir API Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Insourced of Famciclovir API Revenue Market Share by Application
3.3.2 Outsourced of Famciclovir API Revenue Market Share by Application
3.3.3 Others of Famciclovir API Revenue Market Share by Application
4 Global Famciclovir API by Manufacturers
4.1 Global Top Famciclovir API Manufacturers by Sales (2020-2025)
4.1.1 Global Famciclovir API Sales by Manufacturer (2020-2025)
4.1.2 Global Famciclovir API Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Famciclovir API Manufacturers by Revenue (2020-2025)
4.2.1 Global Famciclovir API Revenue by Manufacturer (2020-2025)
4.2.2 Global Famciclovir API Revenue Share by Manufacturer (2020-2025)
4.3 Global Famciclovir API Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Famciclovir API Manufacturers Covered: Ranking by Revenue
4.4.2 Global Famciclovir API Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Famciclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Famciclovir API Manufacturing Base Distribution, Product Type
4.5.1 Famciclovir API Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Famciclovir API Market
4.5.3 Manufacturers Famciclovir API Product Type and Application
4.5.4 Insourced Market Sales of Famciclovir API by Manufacturer
4.5.5 Outsourced Market Sales of Famciclovir API by Manufacturer
4.5.6 Others Market Sales of Famciclovir API by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Chongqing Shenghuaxi Pharma
5.1.1 Chongqing Shenghuaxi Pharma Company Information
5.1.2 Chongqing Shenghuaxi Pharma Description, Business Overview
5.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Products Offered
5.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Chongqing Shenghuaxi Pharma Famciclovir API Sales by Product in 2024
5.1.6 Chongqing Shenghuaxi Pharma Famciclovir API Sales by Application in 2024
5.1.7 Chongqing Shenghuaxi Pharma Famciclovir API Sales by Geographic Area in 2024
5.1.8 Chongqing Shenghuaxi Pharma Recent Developments
5.2 Aurobindo Pharma Limited
5.2.1 Aurobindo Pharma Limited Company Information
5.2.2 Aurobindo Pharma Limited Description, Business Overview
5.2.3 Aurobindo Pharma Limited Famciclovir API Products Offered
5.2.4 Aurobindo Pharma Limited Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Aurobindo Pharma Limited Famciclovir API Sales by Product in 2024
5.2.6 Aurobindo Pharma Limited Famciclovir API Sales by Application in 2024
5.2.7 Aurobindo Pharma Limited Famciclovir API Sales by Geographic Area in 2024
5.2.8 Aurobindo Pharma Limited Recent Developments
5.3 Apotex Pharmachem
5.3.1 Apotex Pharmachem Company Information
5.3.2 Apotex Pharmachem Description, Business Overview
5.3.3 Apotex Pharmachem Famciclovir API Products Offered
5.3.4 Apotex Pharmachem Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Apotex Pharmachem Famciclovir API Sales by Product in 2024
5.3.6 Apotex Pharmachem Famciclovir API Sales by Application in 2024
5.3.7 Apotex Pharmachem Famciclovir API Sales by Geographic Area in 2024
5.3.8 Apotex Pharmachem Recent Developments
5.4 Changzhou Kony Pharma Co
5.4.1 Changzhou Kony Pharma Co Company Information
5.4.2 Changzhou Kony Pharma Co Description, Business Overview
5.4.3 Changzhou Kony Pharma Co Famciclovir API Products Offered
5.4.4 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Changzhou Kony Pharma Co Famciclovir API Sales by Product in 2024
5.4.6 Changzhou Kony Pharma Co Famciclovir API Sales by Application in 2024
5.4.7 Changzhou Kony Pharma Co Famciclovir API Sales by Geographic Area in 2024
5.4.8 Changzhou Kony Pharma Co Recent Developments
5.5 Teva Pharmaceutical Industries
5.5.1 Teva Pharmaceutical Industries Company Information
5.5.2 Teva Pharmaceutical Industries Description, Business Overview
5.5.3 Teva Pharmaceutical Industries Famciclovir API Products Offered
5.5.4 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Teva Pharmaceutical Industries Famciclovir API Sales by Product in 2024
5.5.6 Teva Pharmaceutical Industries Famciclovir API Sales by Application in 2024
5.5.7 Teva Pharmaceutical Industries Famciclovir API Sales by Geographic Area in 2024
5.5.8 Teva Pharmaceutical Industries Recent Developments
5.6 Olon
5.6.1 Olon Company Information
5.6.2 Olon Description, Business Overview
5.6.3 Olon Famciclovir API Products Offered
5.6.4 Olon Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Olon Famciclovir API Sales by Product in 2024
5.6.6 Olon Famciclovir API Sales by Application in 2024
5.6.7 Olon Famciclovir API Sales by Geographic Area in 2024
5.6.8 Olon Recent Developments
5.7 Fuan Pharmaceutical
5.7.1 Fuan Pharmaceutical Company Information
5.7.2 Fuan Pharmaceutical Description, Business Overview
5.7.3 Fuan Pharmaceutical Famciclovir API Products Offered
5.7.4 Fuan Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Fuan Pharmaceutical Famciclovir API Sales by Product in 2024
5.7.6 Fuan Pharmaceutical Famciclovir API Sales by Application in 2024
5.7.7 Fuan Pharmaceutical Famciclovir API Sales by Geographic Area in 2024
5.7.8 Fuan Pharmaceutical Recent Developments
5.8 Zhejiang Charioteer Pharmaceutical
5.8.1 Zhejiang Charioteer Pharmaceutical Company Information
5.8.2 Zhejiang Charioteer Pharmaceutical Description, Business Overview
5.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Products Offered
5.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales by Product in 2024
5.8.6 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales by Application in 2024
5.8.7 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales by Geographic Area in 2024
5.8.8 Zhejiang Charioteer Pharmaceutical Recent Developments
5.9 Jialin Pharmaceutical
5.9.1 Jialin Pharmaceutical Company Information
5.9.2 Jialin Pharmaceutical Description, Business Overview
5.9.3 Jialin Pharmaceutical Famciclovir API Products Offered
5.9.4 Jialin Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Jialin Pharmaceutical Famciclovir API Sales by Product in 2024
5.9.6 Jialin Pharmaceutical Famciclovir API Sales by Application in 2024
5.9.7 Jialin Pharmaceutical Famciclovir API Sales by Geographic Area in 2024
5.9.8 Jialin Pharmaceutical Recent Developments
5.10 Zhejiang Hisun
5.10.1 Zhejiang Hisun Company Information
5.10.2 Zhejiang Hisun Description, Business Overview
5.10.3 Zhejiang Hisun Famciclovir API Products Offered
5.10.4 Zhejiang Hisun Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Zhejiang Hisun Famciclovir API Sales by Product in 2024
5.10.6 Zhejiang Hisun Famciclovir API Sales by Application in 2024
5.10.7 Zhejiang Hisun Famciclovir API Sales by Geographic Area in 2024
5.10.8 Zhejiang Hisun Recent Developments
5.11 Hetero
5.11.1 Hetero Company Information
5.11.2 Hetero Description, Business Overview
5.11.3 Hetero Famciclovir API Products Offered
5.11.4 Hetero Famciclovir API Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Hetero Famciclovir API Sales by Product in 2024
5.11.6 Hetero Famciclovir API Sales by Application in 2024
5.11.7 Hetero Famciclovir API Sales by Geographic Area in 2024
5.11.8 Hetero Recent Developments
6 North America
6.1 North America Famciclovir API Market Size YoY Growth 2020-2031
6.2 North America Famciclovir API Market Facts & Figures by Country
6.2.1 North America Famciclovir API Sales by Country (2020-2031)
6.2.2 North America Famciclovir API Revenue by Country (2020-2031)
6.3 North America Famciclovir API Sales by Type (2020-2025)
6.4 North America Famciclovir API Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Famciclovir API Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Famciclovir API Market Facts & Figures by Region
7.2.1 Asia-Pacific Famciclovir API Sales by Region (2020-2031)
7.2.2 Asia-Pacific Famciclovir API Revenue by Region (2020-2031)
7.3 Asia-Pacific Famciclovir API Sales by Type (2020-2025)
7.4 Asia-Pacific Famciclovir API Sales by Application (2020-2025)
8 Europe
8.1 Europe Famciclovir API Market Size YoY Growth 2020-2031
8.2 Europe Famciclovir API Market Facts & Figures by Country
8.2.1 Europe Famciclovir API Sales by Country (2020-2031)
8.2.2 Europe Famciclovir API Revenue by Country (2020-2031)
8.3 Europe Famciclovir API Sales by Type (2020-2025)
8.4 Europe Famciclovir API Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Famciclovir API Market Size YoY Growth 2020-2031
9.2 Latin America Famciclovir API Market Facts & Figures by Country
9.2.1 Latin America Famciclovir API Sales by Country (2020-2031)
9.2.2 Latin America Famciclovir API Revenue by Country (2020-2031)
9.3 Latin America Famciclovir API Sales by Type (2020-2025)
9.4 Latin America Famciclovir API Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Famciclovir API Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Famciclovir API Market Facts & Figures by Country
10.2.1 Middle East and Africa Famciclovir API Sales by Country (2020-2031)
10.2.2 Middle East and Africa Famciclovir API Revenue by Country (2020-2031)
10.3 Middle East and Africa Famciclovir API Sales by Type (2020-2025)
10.4 Middle East and Africa Famciclovir API Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Famciclovir API Supply Chain Analysis
11.2 Famciclovir API Key Raw Materials and Upstream Suppliers
11.3 Famciclovir API Clients Analysis
11.4 Famciclovir API Sales Channel and Sales Model Analysis
11.4.1 Famciclovir API Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Famciclovir API Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Famciclovir API Distributors
12 Famciclovir API Market Dynamics
12.1 Famciclovir API Industry Trends
12.2 Famciclovir API Market Drivers
12.3 Famciclovir API Market Challenges
12.4 Famciclovir API Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Famciclovir API Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Famciclovir API Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Famciclovir API Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Famciclovir API Sales by Region (2020-2025) & (KG)
Table 5. Global Famciclovir API Sales Forecast by Region (2026-2031) & (KG)
Table 6. Global Famciclovir API Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Famciclovir API Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Famciclovir API Sales Volume by Type (2020-2025) & (KG)
Table 9. Global Famciclovir API Sales Volume by Type (2026-2031) & (KG)
Table 10. Global Famciclovir API Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Famciclovir API Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Famciclovir API Sales Volume by Application (2020-2025) & (KG)
Table 13. Global Famciclovir API Sales Volume by Application (2026-2031) & (KG)
Table 14. Global Famciclovir API Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Famciclovir API Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Famciclovir API Sales by Manufacturer (2020-2025) & (KG)
Table 17. Global Famciclovir API Sales Share by Manufacturer (2020-2025)
Table 18. Famciclovir API Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Famciclovir API Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Famciclovir API Price (2020-2025) & (US$/KG)
Table 21. Ranking of Global Top Famciclovir API Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Famciclovir API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Famciclovir API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir API as of 2024)
Table 24. Famciclovir API Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Famciclovir API Market
Table 26. Manufacturers Famciclovir API Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Chongqing Shenghuaxi Pharma Company Information
Table 29. Chongqing Shenghuaxi Pharma Description and Business Overview
Table 30. Chongqing Shenghuaxi Pharma Famciclovir API Product
Table 31. Chongqing Shenghuaxi Pharma Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 32. Chongqing Shenghuaxi Pharma Sales Proportion of Famciclovir API by Product in 2024
Table 33. Chongqing Shenghuaxi Pharma Sales Proportion of Famciclovir API by Application in 2024
Table 34. Chongqing Shenghuaxi Pharma Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 35. Chongqing Shenghuaxi Pharma Recent Developments
Table 36. Aurobindo Pharma Limited Company Information
Table 37. Aurobindo Pharma Limited Description and Business Overview
Table 38. Aurobindo Pharma Limited Famciclovir API Product
Table 39. Aurobindo Pharma Limited Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 40. Aurobindo Pharma Limited Sales Proportion of Famciclovir API by Product in 2024
Table 41. Aurobindo Pharma Limited Sales Proportion of Famciclovir API by Application in 2024
Table 42. Aurobindo Pharma Limited Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 43. Aurobindo Pharma Limited Recent Developments
Table 44. Apotex Pharmachem Company Information
Table 45. Apotex Pharmachem Description and Business Overview
Table 46. Apotex Pharmachem Famciclovir API Product
Table 47. Apotex Pharmachem Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 48. Apotex Pharmachem Sales Proportion of Famciclovir API by Product in 2024
Table 49. Apotex Pharmachem Sales Proportion of Famciclovir API by Application in 2024
Table 50. Apotex Pharmachem Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 51. Apotex Pharmachem Recent Developments
Table 52. Changzhou Kony Pharma Co Company Information
Table 53. Changzhou Kony Pharma Co Description and Business Overview
Table 54. Changzhou Kony Pharma Co Famciclovir API Product
Table 55. Changzhou Kony Pharma Co Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 56. Changzhou Kony Pharma Co Sales Proportion of Famciclovir API by Product in 2024
Table 57. Changzhou Kony Pharma Co Sales Proportion of Famciclovir API by Application in 2024
Table 58. Changzhou Kony Pharma Co Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 59. Changzhou Kony Pharma Co Recent Developments
Table 60. Teva Pharmaceutical Industries Company Information
Table 61. Teva Pharmaceutical Industries Description and Business Overview
Table 62. Teva Pharmaceutical Industries Famciclovir API Product
Table 63. Teva Pharmaceutical Industries Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 64. Teva Pharmaceutical Industries Sales Proportion of Famciclovir API by Product in 2024
Table 65. Teva Pharmaceutical Industries Sales Proportion of Famciclovir API by Application in 2024
Table 66. Teva Pharmaceutical Industries Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 67. Teva Pharmaceutical Industries Recent Developments
Table 68. Olon Company Information
Table 69. Olon Description and Business Overview
Table 70. Olon Famciclovir API Product
Table 71. Olon Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 72. Olon Sales Proportion of Famciclovir API by Product in 2024
Table 73. Olon Sales Proportion of Famciclovir API by Application in 2024
Table 74. Olon Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 75. Olon Recent Developments
Table 76. Fuan Pharmaceutical Company Information
Table 77. Fuan Pharmaceutical Description and Business Overview
Table 78. Fuan Pharmaceutical Famciclovir API Product
Table 79. Fuan Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 80. Fuan Pharmaceutical Sales Proportion of Famciclovir API by Product in 2024
Table 81. Fuan Pharmaceutical Sales Proportion of Famciclovir API by Application in 2024
Table 82. Fuan Pharmaceutical Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 83. Fuan Pharmaceutical Recent Developments
Table 84. Zhejiang Charioteer Pharmaceutical Company Information
Table 85. Zhejiang Charioteer Pharmaceutical Description and Business Overview
Table 86. Zhejiang Charioteer Pharmaceutical Famciclovir API Product
Table 87. Zhejiang Charioteer Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 88. Zhejiang Charioteer Pharmaceutical Sales Proportion of Famciclovir API by Product in 2024
Table 89. Zhejiang Charioteer Pharmaceutical Sales Proportion of Famciclovir API by Application in 2024
Table 90. Zhejiang Charioteer Pharmaceutical Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 91. Zhejiang Charioteer Pharmaceutical Recent Developments
Table 92. Jialin Pharmaceutical Company Information
Table 93. Jialin Pharmaceutical Description and Business Overview
Table 94. Jialin Pharmaceutical Famciclovir API Product
Table 95. Jialin Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 96. Jialin Pharmaceutical Sales Proportion of Famciclovir API by Product in 2024
Table 97. Jialin Pharmaceutical Sales Proportion of Famciclovir API by Application in 2024
Table 98. Jialin Pharmaceutical Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 99. Jialin Pharmaceutical Recent Developments
Table 100. Zhejiang Hisun Company Information
Table 101. Zhejiang Hisun Description and Business Overview
Table 102. Zhejiang Hisun Famciclovir API Product
Table 103. Zhejiang Hisun Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 104. Zhejiang Hisun Sales Proportion of Famciclovir API by Product in 2024
Table 105. Zhejiang Hisun Sales Proportion of Famciclovir API by Application in 2024
Table 106. Zhejiang Hisun Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 107. Zhejiang Hisun Recent Developments
Table 108. Hetero Company Information
Table 109. Hetero Description and Business Overview
Table 110. Hetero Famciclovir API Product
Table 111. Hetero Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 112. Hetero Sales Proportion of Famciclovir API by Product in 2024
Table 113. Hetero Sales Proportion of Famciclovir API by Application in 2024
Table 114. Hetero Sales Proportion of Famciclovir API by Geographic Area in 2024
Table 115. Hetero Recent Developments
Table 116. North America Famciclovir API Sales by Country (2020-2025) & (KG)
Table 117. North America Famciclovir API Sales by Country (2026-2031) & (KG)
Table 118. North America Famciclovir API Revenue by Country (2020-2025) & (US$ Million)
Table 119. North America Famciclovir API Revenue by Country (2026-2031) & (US$ Million)
Table 120. North America Famciclovir API Sales by Type (2020-2025) & (KG)
Table 121. North America Famciclovir API Sales by Application (2020-2025) & (KG)
Table 122. Asia-Pacific Famciclovir API Sales by Region (2020-2025) & (KG)
Table 123. Asia-Pacific Famciclovir API Sales by Region (2026-2031) & (KG)
Table 124. Asia-Pacific Famciclovir API Revenue by Region (2020-2025) & (US$ Million)
Table 125. Asia-Pacific Famciclovir API Revenue by Region (2026-2031) & (US$ Million)
Table 126. Asia-Pacific Famciclovir API Sales by Type (2020-2025) & (KG)
Table 127. Asia-Pacific Famciclovir API Sales by Application (2020-2025) & (KG)
Table 128. Europe Famciclovir API Sales by Country (2020-2025) & (KG)
Table 129. Europe Famciclovir API Sales by Country (2026-2031) & (KG)
Table 130. Europe Famciclovir API Revenue by Country (2020-2025) & (US$ Million)
Table 131. Europe Famciclovir API Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Famciclovir API Sales by Type (2020-2025) & (KG)
Table 133. Europe Famciclovir API Sales by Application (2020-2025) & (KG)
Table 134. Latin America Famciclovir API Sales by Country (2020-2025) & (KG)
Table 135. Latin America Famciclovir API Sales by Country (2026-2031) & (KG)
Table 136. Latin America Famciclovir API Revenue by Country (2020-2025) & (US$ Million)
Table 137. Latin America Famciclovir API Revenue by Country (2026-2031) & (US$ Million)
Table 138. Latin America Famciclovir API Sales by Type (2020-2025) & (KG)
Table 139. Latin America Famciclovir API Sales by Application (2020-2025) & (KG)
Table 140. Middle East and Africa Famciclovir API Sales by Country (2020-2025) & (KG)
Table 141. Middle East and Africa Famciclovir API Sales by Country (2026-2031) & (KG)
Table 142. Middle East and Africa Famciclovir API Revenue by Country (2020-2025) & (US$ Million)
Table 143. Middle East and Africa Famciclovir API Revenue by Country (2026-2031) & (US$ Million)
Table 144. Middle East and Africa Famciclovir API Sales by Type (2020-2025) & (KG)
Table 145. Middle East and Africa Famciclovir API Sales by Application (2020-2025) & (KG)
Table 146. Famciclovir API Key Raw Materials, Industry Status and Trend
Table 147. Famciclovir API Key Raw Materials and Upstream Suppliers
Table 148. Famciclovir API Clients Status and Trend
Table 149. Famciclovir API Typical Clients
Table 150. Famciclovir API Distributors
Table 151. Famciclovir API Market Trends
Table 152. Famciclovir API Market Drivers
Table 153. Famciclovir API Market Challenges
Table 154. Famciclovir API Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Famciclovir API Product Picture
Figure 2. Global Famciclovir API Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Famciclovir API Sales Market Share by Type in 2024 & 2031
Figure 4. Insourced Product Picture
Figure 5. Outsourced Product Picture
Figure 6. Others Product Picture
Figure 7. Global Famciclovir API Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Famciclovir API Sales Market Share by Application in 2024 & 2031
Figure 9. Tablet Product
Figure 10. Capsule Product
Figure 11. Others
Figure 12. Famciclovir API Report Years Considered
Figure 13. Global Famciclovir API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Famciclovir API Market Size 2020-2031 (US$ Million)
Figure 15. Global Famciclovir API Sales 2020-2031 (KG)
Figure 16. Global Famciclovir API Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Famciclovir API Revenue Market Share by Region (2020-2031)
Figure 18. Global Famciclovir API Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Famciclovir API Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Famciclovir API Average Selling Price (ASP) by Type (2020-2025) & (US$/KG)
Figure 21. Global Famciclovir API Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Famciclovir API Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Famciclovir API Average Selling Price (ASP) by Application (2020-2025) & (US$/KG)
Figure 24. Insourced of Famciclovir API Revenue Market Share by Application, 2024 VS 2031
Figure 25. Outsourced of Famciclovir API Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Famciclovir API Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Famciclovir API Sales Share by Manufacturer in 2024
Figure 28. Famciclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Insourced Market Sales Proportion by Manufacturer in 2024
Figure 30. Outsourced Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Famciclovir API Revenue 2020-2031 (US$ Million)
Figure 33. North America Famciclovir API Sales Market Share by Type (2020-2025)
Figure 34. North America Famciclovir API Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Famciclovir API Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Famciclovir API Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Famciclovir API Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Famciclovir API Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Famciclovir API Sales Market Share by Application (2020-2025)
Figure 40. Europe Famciclovir API Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Famciclovir API Sales Market Share by Country (2020-2031)
Figure 42. Europe Famciclovir API Revenue Market Share by Country (2020-2031)
Figure 43. Europe Famciclovir API Sales Market Share by Type (2020-2025)
Figure 44. Europe Famciclovir API Sales Market Share by Application (2020-2025)
Figure 45. Latin America Famciclovir API Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Famciclovir API Sales Market Share by Country (2020-2031)
Figure 47. Latin America Famciclovir API Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Famciclovir API Sales Market Share by Type (2020-2025)
Figure 49. Latin America Famciclovir API Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Famciclovir API Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Famciclovir API Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Famciclovir API Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Famciclovir API Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Famciclovir API Sales Market Share by Application (2020-2025)
Figure 55. Famciclovir API Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Famciclovir API Raw Materials by Region in 2024
Figure 57. Famciclovir API Distribution Channels
Figure 58. Global Famciclovir API Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Famciclovir API Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
